Fed Circuit Watch: Regeneron Denied Redemption in Misconduct Case

ethics fed circuit watch patent trials

On December 26, 2017, the Court of Appeals for the Federal Circuit denied a request for rehearing en banc for reconsideration made by Regeneron Pharmaceuticals, Inc., in a precedential decision.  This petition was filed following the original decision affirming specific intent litigation misconduct held in the original appellate case.  Judges Prost, Lourie, Dyk, Moore, O’Malley, …

Continue Reading

PTAB Releases Revision to Operating Procedures for Cases Remanded from Federal Circuit

appeals PTAB trials

On November 16, 2017, the Patent Trial and Appeal Board (PTAB) revised its Standard Operating Procedures 9 (SOP9) involving cases remanded for further review from the Federal Circuit.  These standard operating procedures are administrative rules governing cases as they wind their way through the appeal or trial processes before the Board, and are designed to …

Continue Reading